Join us in-person for the 2025 DTRF "Together We Will" Weekend in Chicago from Sept. 12-13! - Register Today

Kris Vleminckx, PhD, Ghent University

“Investigating EZH2 as a druggable mediator of immune cell exclusion in desmoid tumors.” Year 2 of 2

Jointly funded by the DTRF and Desmoid Tumour Foundation of Canada (DFC)